Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial

AIDS ◽  
2019 ◽  
Vol 33 (2) ◽  
pp. 279-284 ◽  
Author(s):  
Romain Palich ◽  
Jade Ghosn ◽  
Antoine Chaillon ◽  
Valérie Boilet ◽  
Marie-Laure Nere ◽  
...  
1988 ◽  
Vol 16 (1) ◽  
pp. 71-74 ◽  
Author(s):  
R. Milani ◽  
S. Scalambrino ◽  
S. Carrera ◽  
P. Pezzoli ◽  
R. Ruffmann

This preliminary communication reports on a non-randomized pilot type trial of 34 females with urgency after pelvic radiotherapy who were treated with flavoxate hydrochloride for 4 weeks. A dosage of 600 mg/day was given to 21 patients and 1200 mg/day to 13 patients. Clinically, both regimens achieved comparable results. Urodynamically (first desire volume, bladder capacity and pressure at capacity) treatment with 1200 mg/day was significantly superior to 600 mg/day. Both schedules were equally well tolerated by patients and no treatment interruption occurred. A randomized double-blind trial comparing 600 and 1200 mg/day flavoxate hydrochloride is currently underway the results of which will be reported in due course.


2007 ◽  
Vol 177 (4S) ◽  
pp. 35-35
Author(s):  
Gianluca Giannarini ◽  
Andrea Mogorovich ◽  
Girolamo Morelli ◽  
Maurizio De Maria ◽  
Francesca Manassero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document